Logo image of ACU.CA

AURORA SOLAR TECHNOLOGIES IN (ACU.CA) Stock Fundamental Analysis

TSX-V:ACU - CA05207J1084 - Common Stock

0.015 CAD
0 (0%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, ACU scores 1 out of 10 in our fundamental rating. ACU was compared to 13 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of ACU have multiple concerns. ACU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ACU has reported negative net income.
In the past year ACU has reported a negative cash flow from operations.
In the past 5 years ACU always reported negative net income.
In the past 5 years ACU reported 4 times negative operating cash flow.
ACU.CA Yearly Net Income VS EBIT VS OCF VS FCFACU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1M -2M -3M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -45.37%, ACU is doing worse than 69.23% of the companies in the same industry.
With a Return On Equity value of -109.12%, ACU is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -45.37%
ROE -109.12%
ROIC N/A
ROA(3y)-31.68%
ROA(5y)-64.09%
ROE(3y)-64.27%
ROE(5y)-97.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACU.CA Yearly ROA, ROE, ROICACU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

ACU has a Gross Margin of 57.22%. This is amongst the best in the industry. ACU outperforms 92.31% of its industry peers.
ACU's Gross Margin has been stable in the last couple of years.
ACU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y0.6%
ACU.CA Yearly Profit, Operating, Gross MarginsACU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

2

2. Health

2.1 Basic Checks

ACU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACU has about the same amount of shares outstanding.
Compared to 5 years ago, ACU has more shares outstanding
Compared to 1 year ago, ACU has a worse debt to assets ratio.
ACU.CA Yearly Shares OutstandingACU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ACU.CA Yearly Total Debt VS Total AssetsACU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

ACU has an Altman-Z score of -4.57. This is a bad value and indicates that ACU is not financially healthy and even has some risk of bankruptcy.
ACU has a worse Altman-Z score (-4.57) than 76.92% of its industry peers.
ACU has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ACU has a better Debt to Equity ratio (0.01) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -4.57
ROIC/WACCN/A
WACC8.18%
ACU.CA Yearly LT Debt VS Equity VS FCFACU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M

2.3 Liquidity

A Current Ratio of 1.57 indicates that ACU should not have too much problems paying its short term obligations.
ACU has a Current ratio of 1.57. This is in the lower half of the industry: ACU underperforms 69.23% of its industry peers.
A Quick Ratio of 0.61 indicates that ACU may have some problems paying its short term obligations.
The Quick ratio of ACU (0.61) is worse than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.61
ACU.CA Yearly Current Assets VS Current LiabilitesACU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

ACU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1511.11%.
Looking at the last year, ACU shows a very negative growth in Revenue. The Revenue has decreased by -42.33% in the last year.
Measured over the past years, ACU shows a quite strong growth in Revenue. The Revenue has been growing by 13.80% on average per year.
EPS 1Y (TTM)-1511.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)-42.33%
Revenue growth 3YN/A
Revenue growth 5Y13.8%
Sales Q2Q%-59.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACU.CA Yearly Revenue VS EstimatesACU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ACU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACU.CA Price Earnings VS Forward Price EarningsACU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACU.CA Per share dataACU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AURORA SOLAR TECHNOLOGIES IN

TSX-V:ACU (9/5/2025, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-27 2025-08-27
Earnings (Next)11-27 2025-11-27
Inst Owners10.14%
Inst Owner ChangeN/A
Ins Owners2.28%
Ins Owner ChangeN/A
Market Cap3.33M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.3
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.03
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.37%
ROE -109.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.22%
FCFM N/A
ROA(3y)-31.68%
ROA(5y)-64.09%
ROE(3y)-64.27%
ROE(5y)-97.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y0.6%
F-Score3
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.21%
Cap/Sales 5.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.61
Altman-Z -4.57
F-Score3
WACC8.18%
ROIC/WACCN/A
Cap/Depr(3y)48.43%
Cap/Depr(5y)52.71%
Cap/Sales(3y)3.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1511.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.33%
Revenue growth 3YN/A
Revenue growth 5Y13.8%
Sales Q2Q%-59.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1272.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5912.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-513.87%
OCF growth 3YN/A
OCF growth 5YN/A